| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BIOCEL.2013.05.030 |
| P698 | PubMed publication ID | 23748105 |
| P2093 | author name string | Yangchao Chen | |
| Chi Han Li | |||
| P433 | issue | 8 | |
| P304 | page(s) | 1895-1910 | |
| P577 | publication date | 2013-06-04 | |
| P1433 | published in | International Journal of Biochemistry & Cell Biology | Q6051320 |
| P1476 | title | Targeting long non-coding RNAs in cancers: progress and prospects | |
| P478 | volume | 45 |
| Q57790083 | A Three-lncRNA Expression Signature Predicts Survival in Head and neck squamous cell carcinoma (HNSCC) |
| Q41709267 | A five-long non-coding RNA signature to improve prognosis prediction of clear cell renal cell carcinoma |
| Q48146300 | A genetic variant in CDKN2A/B gene is associated with the increased risk of breast cancer. |
| Q40858476 | A pan-cancer analysis of MYC-PVT1 reveals CNV-unmediated deregulation and poor prognosis in renal carcinoma |
| Q91993519 | A perspective profile of ADCY1 in cAMP signaling with drug-resistance in lung cancer |
| Q38692678 | ANRIL: a pivotal tumor suppressor long non-coding RNA in human cancers |
| Q64056479 | Aberrant Expression of Pseudogene-Derived lncRNAs as an Alternative Mechanism of Cancer Gene Regulation in Lung Adenocarcinoma |
| Q36266410 | AlncRNA HULC as an effective biomarker for surveillance of the outcome of cancer: A meta-analysis |
| Q64102464 | An Integrated Regulatory Network Based on Comprehensive Analysis of mRNA Expression, Gene Methylation and Expression of Long Non-coding RNAs (lncRNAs) in Myelodysplastic Syndromes |
| Q38227931 | An update on RNA interference-mediated gene silencing in cancer therapy |
| Q91257730 | Analyzing the Interactions of mRNAs and ncRNAs to Predict Competing Endogenous RNA Networks in Osteosarcoma Chemo-Resistance |
| Q92251829 | Associating lncRNAs with small molecules via bilevel optimization reveals cancer-related lncRNAs |
| Q34135956 | Association of decreased expression of long non-coding RNA LOC285194 with chemoradiotherapy resistance and poor prognosis in esophageal squamous cell carcinoma |
| Q38168041 | Characteristics of long non-coding RNA and its relation to hepatocellular carcinoma |
| Q90420158 | Characterization of a Long Non-Coding RNA, the Antisense RNA of Na/K-ATPase α1 in Human Kidney Cells |
| Q38616693 | Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer |
| Q43653975 | Clinical significance of the low expression of FER1L4 in gastric cancer patients |
| Q94416510 | Co-Expression Network Analysis of Fbxw7-Associated LncRNAs Reveals Their Functions in Radiation-Induced Thymic Lymphoma |
| Q38325485 | Competing endogenous RNA interplay in cancer: mechanism, methodology, and perspectives |
| Q55383227 | Comprehensive analysis of differentially expressed profiles of lncRNAs and mRNAs reveals ceRNA networks in the transformation of diffuse large B-cell lymphoma. |
| Q37520568 | Comprehensive analysis of long non-coding RNA expression profiles in hepatitis B virus-related hepatocellular carcinoma |
| Q92815640 | Copy number variations primed lncRNAs deregulation contribute to poor prognosis in colorectal cancer |
| Q37709328 | Correlation of long non-coding RNA H19 expression with cisplatin-resistance and clinical outcome in lung adenocarcinoma |
| Q34584549 | Could lncRNAs be the missing links in control of mesenchymal stem cell differentiation? |
| Q47101032 | Crosstalk between the Notch signaling pathway and non-coding RNAs in gastrointestinal cancers |
| Q38543780 | Current and future molecular diagnostics in non-small-cell lung cancer. |
| Q43670482 | Development of novel long noncoding RNA MALAT1 near-infrared optical probes for in vivo tumour imaging |
| Q35850934 | Diagnostic value of the UCA1 test for bladder cancer detection: a clinical study |
| Q31083417 | Discovering and understanding oncogenic gene fusions through data intensive computational approaches |
| Q58781865 | Downregulation of lncRNA suppresses growth and metastasis in human osteosarcoma cells |
| Q38813218 | Downregulation of lncRNA-MALAT1 Affects Proliferation and the Expression of Stemness Markers in Glioma Stem Cell Line SHG139S. |
| Q37565191 | Downregulation of long non-coding RNA ANRIL suppresses lymphangiogenesis and lymphatic metastasis in colorectal cancer |
| Q89495275 | Dysregulated lncRNA-miRNA-mRNA Network Reveals Patient Survival-Associated Modules and RNA Binding Proteins in Invasive Breast Carcinoma |
| Q37582014 | Dysregulation of MALAT1 and miR-619-5p as a prognostic indicator in advanced colorectal carcinoma |
| Q43763207 | Effect of HOTAIR rs920778 polymorphism on breast cancer susceptibility and clinicopathologic features in a Turkish population |
| Q47630987 | Emerging Role of MicroRNAs and Long Noncoding RNAs in Healthy and Diseased Lung |
| Q61812183 | Emerging role of long non-coding RNA MALAT1 in predicting clinical outcomes of patients with digestive system malignancies: A meta-analysis |
| Q57105553 | Emerging ways to treat breast cancer: will promises be met? |
| Q38275276 | Epigenetic targets for novel therapies of lung diseases |
| Q37615798 | Epigenetics of oropharyngeal squamous cell carcinoma: opportunities for novel chemotherapeutic targets |
| Q89883621 | Expression and Effects of Long Non-Coding RNA, LINC01124, in Non-Small Cell Lung Cancer |
| Q36169008 | Expression and clinical significance of long non-coding RNA HNF1A-AS1 in human gastric cancer |
| Q64286882 | Expression of long non-coding RNA ENSG00000226738 (LncKLHDC7B) is enriched in the immunomodulatory triple-negative breast cancer subtype and its alteration promotes cell migration, invasion, and resistance to cell death |
| Q33721461 | Expression pattern of long non-coding RNAs in renal cell carcinoma revealed by microarray |
| Q35024083 | From discovery to function: the expanding roles of long noncoding RNAs in physiology and disease |
| Q35158537 | Genetic Background Modulates lncRNA-Coordinated Tissue Response to Low Dose Ionizing Radiation. |
| Q47747985 | HOTAIR Long Non-coding RNA: Characterizing the Locus Features by the In Silico Approaches. |
| Q36880407 | HOX genes: Major actors in resistance to selective endocrine response modifiers |
| Q36174441 | HULC cooperates with MALAT1 to aggravate liver cancer stem cells growth through telomere repeat-binding factor 2. |
| Q33898623 | High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer |
| Q41466279 | Histone code and long non-coding RNAs (lncRNAs) aberrations in lung cancer: implications in the therapy response. |
| Q41365240 | Identification of key lncRNAs in colorectal cancer progression based on associated protein-protein interaction analysis |
| Q37619647 | Identification of the lncRNA, AK156230, as a novel regulator of cellular senescence in mouse embryonic fibroblasts |
| Q38648079 | Influence of the interaction between long noncoding RNAs and hypoxia on tumorigenesis |
| Q58587985 | Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR‑34a/cyclin D1 axis |
| Q92024865 | LINC00459 sponging miR-218 to elevate DKK3 inhibits proliferation and invasion in melanoma |
| Q90423819 | LINC00470 Coordinates the Epigenetic Regulation of ELFN2 to Distract GBM Cell Autophagy |
| Q48265359 | LINC00473 antagonizes the tumour suppressor miR-195 to mediate the pathogenesis of Wilms tumour via IKKα. |
| Q98499631 | LINC00675 activates androgen receptor axis signaling pathway to promote castration-resistant prostate cancer progression |
| Q64120609 | LINC01296 promotes proliferation, migration, and invasion of HCC cells by targeting miR-122-5P and modulating EMT activity |
| Q45884861 | LOC100287225, novel long intergenic non-coding RNA, misregulates in colorectal cancer. |
| Q88810263 | LncRNA ABHD11-AS1 promotes the development of endometrial carcinoma by targeting cyclin D1 |
| Q26799778 | LncRNA HOTAIR: A master regulator of chromatin dynamics and cancer |
| Q47164183 | LncRNA MALAT1 is dysregulated in diabetic nephropathy and involved in high glucose-induced podocyte injury via its interplay with β-catenin. |
| Q89640433 | LncRNA MATN1-AS1 prevents glioblastoma cell from proliferation and invasion via RELA regulation and MAPK signaling pathway |
| Q91767461 | LncRNA MIR22HG abrogation inhibits proliferation and induces apoptosis in esophageal adenocarcinoma cells via activation of the STAT3/c-Myc/FAK signaling |
| Q89998044 | LncRNA PLAC 2 downregulated miR-21 in non-small cell lung cancer and predicted survival |
| Q99565249 | LncRNA SNHG9 is Downregulated in Non-Small Cell Lung Cancer and Suppressed miR-21 Through Methylation to Promote Cell Proliferation |
| Q98945419 | LncRNA TBX5-AS1 Regulates the Tumor Progression Through the PI3K/AKT Pathway in Non-Small Cell Lung Cancer |
| Q58759156 | LncRNA TUG1 promotes cells proliferation and inhibits cells apoptosis through regulating AURKA in epithelial ovarian cancer cells |
| Q47261037 | LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma |
| Q58090484 | LncRNA2Target v2.0: a comprehensive database for target genes of lncRNAs in human and mouse |
| Q28081981 | LncRNAs: emerging players in gene regulation and disease pathogenesis |
| Q93079843 | Long Non-Coding RNA in the Pathogenesis of Cancers |
| Q26778147 | Long Non-Coding RNAs in Endometrial Carcinoma |
| Q90398671 | Long Non-coding RNAs Mechanisms of Action in HIV-1 Modulation and the Identification of Novel Therapeutic Targets |
| Q90403271 | Long Non-coding RNAs as Functional and Structural Chromatin Modulators in Acute Myeloid Leukemia |
| Q36427088 | Long Noncoding RNA CUDR Regulates HULC and β-Catenin to Govern Human Liver Stem Cell Malignant Differentiation |
| Q41408442 | Long Noncoding RNAs Act as Novel Biomarkers for Hepatocellular Carcinoma: Progress and Prospects |
| Q41553095 | Long Noncoding RNAs as Diagnostic and Therapeutic Targets in Type 2 Diabetes and Related Complications |
| Q26785935 | Long Noncoding RNAs as New Architects in Cancer Epigenetics, Prognostic Biomarkers, and Potential Therapeutic Targets |
| Q52573162 | Long non-coding RNA (lncRNA) MAGI2-AS3 inhibits breast cancer cell growth by targeting the Fas/FasL signalling pathway. |
| Q38771232 | Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma |
| Q37733077 | Long non-coding RNA GAS5 inhibits tumorigenesis via miR-137 in melanoma |
| Q90443553 | Long non-coding RNA LOC285194 functions as a tumor suppressor by targeting p53 in non-small cell lung cancer |
| Q38884574 | Long non-coding RNA Linc-ITGB1 knockdown inhibits cell migration and invasion in GBC-SD/M and GBC-SD gallbladder cancer cell lines |
| Q36120698 | Long non-coding RNA MALAT-1 modulates metastatic potential of tongue squamous cell carcinomas partially through the regulation of small proline rich proteins |
| Q42316811 | Long non-coding RNA PVT1 promotes osteosarcoma development by acting as a molecular sponge to regulate miR-195. |
| Q58573269 | Long non-coding RNA SUMO1P3 may promote cell proliferation, migration, and invasion of pancreatic cancer via EMT signaling pathway |
| Q64982424 | Long non-coding RNA TPTEP1 inhibits hepatocellular carcinoma progression by suppressing STAT3 phosphorylation. |
| Q55425914 | Long non-coding RNA XIST predicts worse prognosis in digestive system tumors: a systemic review and meta-analysis. |
| Q26801406 | Long non-coding RNA and chromatin remodeling |
| Q38645336 | Long non-coding RNA and tumor hypoxia: new players ushered toward an old arena |
| Q38295509 | Long non-coding RNA expression profiles of hepatitis C virus-related dysplasia and hepatocellular carcinoma |
| Q38431140 | Long non-coding RNA functions in lung cancer |
| Q36085374 | Long non-coding RNA growth arrest-specific transcript 5 in tumor biology |
| Q47712916 | Long non-coding RNA implicated in the invasion and metastasis of head and neck cancer: possible function and mechanisms |
| Q38826313 | Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12) promotes cell proliferation and migration by upregulating angiomotin gene expression in human osteosarcoma cells |
| Q54919232 | Long non-coding RNA taurine-upregulated gene 1 predicts unfavorable prognosis, promotes cells proliferation, and inhibits cells apoptosis in epithelial ovarian cancer. |
| Q34607635 | Long non-coding RNAs and hepatocellular carcinoma |
| Q33582854 | Long non-coding RNAs as novel biomarkers and therapeutic targets in head and neck cancers |
| Q47138075 | Long non-coding RNAs in Colorectal Cancer: Progression and Future Directions |
| Q39246325 | Long non-coding RNAs in cutaneous melanoma: clinical perspectives. |
| Q59329575 | Long non-coding RNAs in hematological malignancies: translating basic techniques into diagnostic and therapeutic strategies |
| Q33591871 | Long non-coding RNAs: a rising biotarget in colorectal cancer |
| Q34685418 | Long non-coding RNAs: critical players in hepatocellular carcinoma |
| Q38244861 | Long non-coding RNAs: emerging players in gastric cancer |
| Q38683315 | Long non-coding RNAs: emerging players in osteosarcoma |
| Q64989083 | Long noncoding RNA ANCR inhibits the differentiation of mesenchymal stem cells toward definitive endoderm by facilitating the association of PTBP1 with ID2. |
| Q90929398 | Long noncoding RNA CAR10 promotes lung adenocarcinoma metastasis via miR-203/30/SNAI axis |
| Q36093282 | Long noncoding RNA TUG1 is downregulated in non-small cell lung cancer and can regulate CELF1 on binding to PRC2. |
| Q39131048 | Long noncoding RNAs as novel serum biomarkers for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis |
| Q38996024 | Long noncoding RNAs in head and neck cancer |
| Q26775818 | Long noncoding RNAs in hepatocellular carcinoma: Novel insights into their mechanism |
| Q38200054 | Long noncoding RNAs: emerging stars in gene regulation, epigenetics and human disease. |
| Q38703098 | Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy |
| Q38944003 | Long noncoding and circular RNAs in lung cancer: advances and perspectives |
| Q88636857 | MEF2‑activated long non‑coding RNA PCGEM1 promotes cell proliferation in hormone‑refractory prostate cancer through downregulation of miR‑148a |
| Q35994443 | MicroRNAs and other non-coding RNAs as targets for anticancer drug development |
| Q90118447 | Molecular mechanisms of circular RNAs, transforming growth factor-β, and long noncoding RNAs in hepatocellular carcinoma |
| Q64053604 | Molecular pattern of lncRNAs in hepatocellular carcinoma |
| Q39368869 | Multiple functions of long non-coding RNAs in oxidative stress, DNA damage response and cancer progression. |
| Q38720417 | NEAT1: A novel cancer-related long non-coding RNA. |
| Q27020939 | Natural antisense transcripts |
| Q35139020 | Neighboring gene regulation by antisense long non-coding RNAs |
| Q37258866 | Next generation deep sequencing identified a novel lncRNA n375709 associated with paclitaxel resistance in nasopharyngeal carcinoma |
| Q64253468 | Non-Coding RNAs as New Therapeutic Targets in the Context of Renal Fibrosis |
| Q90734648 | Non-coding RNAs as Regulators of Lymphangiogenesis in Lymphatic Development, Inflammation, and Cancer Metastasis |
| Q33829653 | Non-coding RNAs as emerging regulators of epithelial to mesenchymal transition in non-small cell lung cancer |
| Q38586823 | Non-coding RNAs deregulation in oral squamous cell carcinoma: advances and challenges |
| Q38514715 | Non-coding RNAs: Epigenetic regulators of bone development and homeostasis |
| Q35592207 | Noncoding RNA as therapeutic targets for hepatocellular carcinoma. |
| Q26774630 | Noncoding RNAs and pancreatic cancer |
| Q28080346 | Noncoding RNAs in Tumor Epithelial-to-Mesenchymal Transition |
| Q26996781 | Noncoding RNAs: emerging players in muscular dystrophies |
| Q24564267 | Novel therapeutic targets for pancreatic cancer |
| Q33774226 | Overexpression of LINC00152 correlates with poor patient survival and knockdown impairs cell proliferation in lung cancer |
| Q92868511 | Overexpression of ZEB2-AS1 promotes epithelial-to-mesenchymal transition and metastasis by stabilizing ZEB2 mRNA in head neck squamous cell carcinoma |
| Q93114675 | PTB-AS, a Novel Natural Antisense Transcript, Promotes Glioma Progression by Improving PTBP1 mRNA Stability with SND1 |
| Q98159032 | Pan-cancer analysis reveals the role of long non-coding RNA LINC01614 as a highly cancer-dependent oncogene and biomarker |
| Q37582231 | Plasma lncRNA-GACAT2 is a valuable marker for the screening of gastric cancer |
| Q37681322 | Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions |
| Q64073595 | Potential Role of lncRNA H19 as a Cancer Biomarker in Human Cancers Detection and Diagnosis: A Pooled Analysis Based on 1585 Subjects |
| Q59809159 | Potential clinical application of lncRNAs in non-small cell lung cancer |
| Q39410767 | Prognostic and clinicopathological role of long non-coding RNA taurine upregulated 1 in various human malignancies: A systemic review and meta-analysis. |
| Q55457425 | Prognostic and clinicopathological significance of long non-coding RNA in glioma. |
| Q91840477 | Prognostic value of long non-coding RNA GHET1 in cancers: a systematic review and meta-analysis |
| Q39275455 | Pseudogenes in gastric cancer pathogenesis: a review article |
| Q89638490 | Re-recognition of pseudogenes: From molecular to clinical applications |
| Q53048458 | Recent advances in epigenomics in NSCLC: real-time detection and therapeutic implications. |
| Q34023658 | Regulation of the mRNA half-life in breast cancer |
| Q26797350 | Regulatory Roles of Non-Coding RNAs in Colorectal Cancer |
| Q36124946 | Reprogramming during epithelial to mesenchymal transition under the control of TGFβ |
| Q38207394 | Role of epigenetic mechanisms in epithelial-to-mesenchymal transition of breast cancer cells |
| Q33727024 | Roles of Long Non-Coding RNAs on Tumorigenesis and Glioma Development |
| Q33889417 | Roles of long noncoding RNAs in colorectal cancer metastasis |
| Q38570602 | Satellite non-coding RNAs: the emerging players in cells, cellular pathways and cancer |
| Q36608200 | Small and Long Non-Coding RNAs: Novel Targets in Perspective Cancer Therapy. |
| Q57043976 | Specific expression of lncRNA RP13-650J16.1 and TCONS_00023979 in prostate cancer |
| Q92761432 | Stress-induced lncRNA LASTR fosters cancer cell fitness by regulating the activity of the U4/U6 recycling factor SART3 |
| Q92094947 | System level characterization of small molecule drugs and their affected long noncoding RNAs |
| Q35830257 | TGFβ1 secreted by cancer-associated fibroblasts induces epithelial-mesenchymal transition of bladder cancer cells through lncRNA-ZEB2NAT. |
| Q38875365 | TUG1: a pivotal oncogenic long non-coding RNA of human cancers |
| Q26739969 | Tamoxifen Resistance: Emerging Molecular Targets |
| Q47446459 | The GAS5/miR-222 Axis Regulates Proliferation of Gastric Cancer Cells Through the PTEN/Akt/mTOR Pathway |
| Q38578754 | The RNA world in the 21st century-a systems approach to finding non-coding keys to clinical questions. |
| Q36921385 | The Widening Sphere of Influence of HOXB7 in Solid Tumors |
| Q28070337 | The crosstalk between lncRNA and microRNA in cancer metastasis: orchestrating the epithelial-mesenchymal plasticity |
| Q38239897 | The decalog of long non-coding RNA involvement in cancer diagnosis and monitoring. |
| Q38262017 | The fusion of two worlds: non-coding RNAs and extracellular vesicles--diagnostic and therapeutic implications (Review). |
| Q38746243 | The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway |
| Q38702614 | The inhibitory effect of MEG3/miR-214/AIFM2 axis on the growth of T-cell lymphoblastic lymphoma |
| Q49667633 | The interaction of lncRNA EZR-AS1 with SMYD3 maintains overexpression of EZR in ESCC cells. |
| Q89514252 | The interplay between HIF-1α and noncoding RNAs in cancer |
| Q93360009 | The lncRNA BORG facilitates the survival and chemoresistance of triple-negative breast cancers |
| Q92217658 | The lncRNA SLNCR Recruits the Androgen Receptor to EGR1-Bound Genes in Melanoma and Inhibits Expression of Tumor Suppressor p21 |
| Q38241414 | The lncRNA-MYC regulatory network in cancer |
| Q47721081 | The long noncoding RNA CASC2 inhibits tumorigenesis through modulating the expression of PTEN by targeting miR-18a-5p in esophageal carcinoma |
| Q50019259 | The long noncoding RNA HOTAIR promotes colorectal cancer progression by sponging miR-197. |
| Q97072562 | The role of Long Non-Coding RNAs (lncRNAs) and downstream signaling pathways in Leukemia progression |
| Q99417876 | The roles of long noncoding RNAs in breast cancer metastasis |
| Q94564366 | Transcription and Translation Inhibitors in Cancer Treatment |
| Q89285432 | Transcriptome analysis demonstrates that long noncoding RNA is involved in the hypoxic response in Larimichthys crocea |
| Q38899302 | Unraveling the oral cancer lncRNAome: Identification of novel lncRNAs associated with malignant progression and HPV infection |
| Q54245305 | Up-regulation of SUMO1 pseudogene 3 (SUMO1P3) in gastric cancer and its clinical association. |
| Q93027801 | Upregulation of Long Non-Coding RNA ENST00000429227.1 Is Correlated with Poor Prognosis in Human Hepatocellular Carcinoma |
| Q91739194 | Upregulation of MANCR predicts poor survival in patients with gastric cancer |
| Q91456459 | Upregulation of lncRNA ADAMTS9-AS2 Promotes Salivary Adenoid Cystic Carcinoma Metastasis via PI3K/Akt and MEK/Erk Signaling |
| Q38767145 | Upregulation of long noncoding RNA SPRY4-IT1 promotes metastasis of esophageal squamous cell carcinoma via induction of epithelial-mesenchymal transition |
| Q36727839 | Upregulation of the Non-Coding RNA OTUB1-isoform 2 Contributes to Gastric Cancer Cell Proliferation and Invasion and Predicts Poor Gastric Cancer Prognosis |
| Q54198749 | Upregulation of the long noncoding RNA HOTAIR predicts recurrence in stage Ta/T1 bladder cancer. |
| Q57285695 | Viroid research and its significance for RNA technology and basic biochemistry |
| Q38348854 | lincRNA HOTAIR as a novel promoter of cancer progression. |
| Q90623129 | lncRNA involvement in hepatocellular carcinoma metastasis and prognosis |
| Q94470127 | miR-548e Sponged by ZFAS1 Regulates Metastasis and Cisplatin Resistance of OC by Targeting CXCR4 and let-7a/BCL-XL/S Signaling Axis |
Search more.